Results 111 to 120 of about 1,651 (123)

activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant biofilms

International Journal of Antimicrobial Agents, 2018
Melissa Karau, Yash Raval
exaly  

Evaluation of Non-Tissue Culture- versus Tissue Culture-Treated Microplates for Oritavancin Susceptibility Testing.

Journal of Clinical Microbiology, 2018
Melissa Karau
exaly  

Treatment of chronic osteomyelitis with multidose oritavancin: A case series and literature review

International Journal of Antimicrobial Agents, 2019
Daniel B Chastain
exaly  

Inhibition of Staphylococcus aureus Cell Wall Biosynthesis by Desleucyl-Oritavancin: a Quantitative Peptidoglycan Composition Analysis by Mass Spectrometry.

Journal of Bacteriology, 2017
Sung Joon Kim, Alejandro J Ramirez
exaly  

In vitro time–kill analysis of oritavancin against clinical isolates of methicillin-resistant with reduced susceptibility to daptomycin

Diagnostic Microbiology and Infectious Disease, 2011
Celine Vidaillac, Jorge Parra-Ruiz
exaly  

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010–2014

Diagnostic Microbiology and Infectious Disease, 2018
Helio S Sader, Rodrigo Mendes, Mariana Castanheira   +2 more
exaly  

In vitro activity of oritavancin against biofilms of staphylococci isolated from prosthetic joint infection

Diagnostic Microbiology and Infectious Disease, 2018
Melissa Karau
exaly  

Pharmacokinetics, safety, and tolerability of ascending single intravenous doses of oritavancin administered to healthy human subjects

Diagnostic Microbiology and Infectious Disease, 2004
Paul Ambrose, Joel S Owen, Sujata M Bhavnani   +2 more
exaly  

Effects of Oritavancin on Coagulation Tests in the Clinical Laboratory.

Antimicrobial Agents and Chemotherapy, 2017
Greg Moeck, Dorothy Adcock, Adam Belley
exaly  

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Infectious Diseases and Therapy, 2016
Karrine Brade, Jeffrey M Rybak
exaly